Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $105,020 | 53 | 71.8% |
| Consulting Fee | $18,846 | 10 | 12.9% |
| Travel and Lodging | $14,734 | 56 | 10.1% |
| Food and Beverage | $7,698 | 106 | 5.3% |
| Education | $2.31 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $78,285 | 97 | $0 (2021) |
| Gilead Sciences, Inc. | $67,184 | 118 | $0 (2024) |
| ABBVIE INC. | $271.87 | 4 | $0 (2022) |
| PORTOLA PHARMACEUTICALS, INC. | $144.86 | 1 | $0 (2018) |
| La Jolla Pharmaceutical Company | $118.56 | 1 | $0 (2018) |
| Allergan, Inc. | $110.48 | 2 | $0 (2020) |
| The Medicines Company | $90.22 | 1 | $0 (2017) |
| PFIZER INC. | $81.50 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $13.98 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25,168 | 42 | Gilead Sciences, Inc. ($25,087) |
| 2023 | $28,756 | 52 | Gilead Sciences, Inc. ($28,742) |
| 2022 | $12,471 | 26 | Gilead Sciences, Inc. ($12,215) |
| 2021 | $3,106 | 7 | Janssen Pharmaceuticals, Inc ($1,950) |
| 2020 | $13,882 | 17 | Janssen Pharmaceuticals, Inc ($13,771) |
| 2019 | $17,433 | 21 | Janssen Pharmaceuticals, Inc ($17,433) |
| 2018 | $16,379 | 19 | Janssen Pharmaceuticals, Inc ($16,116) |
| 2017 | $29,105 | 42 | Janssen Pharmaceuticals, Inc ($29,015) |
All Payment Transactions
226 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $525.00 | General |
| Category: COVID-19 | ||||||
| 11/19/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $108.16 | General |
| Category: COVID-19 | ||||||
| 11/11/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $81.50 | General |
| 10/01/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Consulting Fee | Cash or cash equivalent | $4,750.00 | General |
| Category: COVID-19 | ||||||
| 09/12/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $53.33 | General |
| Category: COVID-19 | ||||||
| 09/12/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $44.44 | General |
| Category: COVID-19 | ||||||
| 09/12/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $38.55 | General |
| Category: COVID-19 | ||||||
| 09/12/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: COVID-19 | ||||||
| 09/11/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $261.06 | General |
| Category: COVID-19 | ||||||
| 09/11/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $108.70 | General |
| Category: COVID-19 | ||||||
| 07/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $145.94 | General |
| 07/15/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: COVID-19 | ||||||
| 07/15/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Consulting Fee | Cash or cash equivalent | $473.00 | General |
| Category: COVID-19 | ||||||
| 05/23/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $97.12 | General |
| 04/24/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $62.42 | General |
| Category: COVID-19 | ||||||
| 04/24/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $45.92 | General |
| Category: COVID-19 | ||||||
| 04/24/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: COVID-19 | ||||||
| 04/22/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,230.00 | General |
| Category: COVID-19 | ||||||
| 04/17/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $846.25 | General |
| Category: COVID-19 | ||||||
| 04/17/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $605.68 | General |
| Category: COVID-19 | ||||||
| 04/17/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $289.36 | General |
| Category: COVID-19 | ||||||
| 04/17/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $72.07 | General |
| Category: COVID-19 | ||||||
| 04/05/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $91.92 | General |
| Category: COVID-19 | ||||||
| 04/05/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $17.62 | General |
| Category: COVID-19 | ||||||
| 03/13/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,230.00 | General |
| Category: COVID-19 | ||||||
About Dr. Patrick Godwin, M.D
Dr. Patrick Godwin, M.D is a Internal Medicine healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801986351.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Godwin, M.D has received a total of $146,300 in payments from pharmaceutical and medical device companies, with $25,168 received in 2024. These payments were reported across 226 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($105,020).
Practice Information
- Specialty Internal Medicine
- Location Chicago, IL
- Active Since 10/13/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1801986351
Products in Payments
- XARELTO (Drug) $78,285
- Veklury (Drug) $60,540
- DALVANCE (Drug) $152.03
- BEVYXXA (Drug) $144.86
- AVYCAZ (Drug) $119.84
- GIAPREZA (Drug) $118.56
- TEFLARO (Drug) $110.48
- VABOMERE (Drug) $90.22
- FARXIGA (Drug) $13.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Chicago
Dr. Myles Wolf, Md, MD
Internal Medicine — Payments: $1.8M
Dr. Merle Diamond, Md, MD
Internal Medicine — Payments: $1.4M
Dr. Elizabeth Kiracofe, M.d, M.D
Internal Medicine — Payments: $1.2M
Robert Kushner, Md, MD
Internal Medicine — Payments: $549,886
Dr. Adam Stein, M.d, M.D
Internal Medicine — Payments: $503,325
Devalingam Mahalingam, M.d, M.D
Internal Medicine — Payments: $501,247